SCHEMBL759047

SCHEMBL759047

Cc1cc2ccccc2oc1=O.Cc1ccc2c(-c3cccc(F)c3)cc(=O)oc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.50
CA9 Q16790 4/20 0.50
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.45
KCNA3 P22001 1/20 0.45
MAOB P27338 7/20 0.43
TDP1 Q9NUW8 3/20 0.43
POLB P06746 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOA P21397 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759601 0.87 CA12 (0.64) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL14883412 0.78 ALDH1A1 (0.72) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL760013 0.76 KDM4E (0.43) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL12226980 0.75 CA9 (0.68) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL28068462 0.74 RAB9A (0.71) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL4077549 0.73 CA12 (0.65) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL21629542 0.72 CA12 (0.72) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL16192601 0.72 ALDH1A1 (0.71) CA12CA9ALDH1A1KDM4EMEN1
SCHEMBL13769543 0.71 CA12 (0.70) CA12CA9ALDH1A1HPGDKDM4E
SCHEMBL30023 0.71 HPGD (0.60) CA12CA9ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118093-B1 [1,2,3]TRIAZOLYL SUBSTITUTED QUINOLINES AND COUMARINS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK CANADA INC (CA) 2012-03-21 EP disclosed
US-7960409-B2 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents MERCK SHARP & DOHME CORP. (US) 2011-06-14 US disclosed